|
|
|
Volumn 67, Issue 10, 2009, Pages 1938-1943
|
|
Immunotherapy and cell therapy for myeloid leukemia
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BCR ABL PROTEIN;
CANCER VACCINE;
LYMPHOCYTE ANTIGEN RECEPTOR;
MYELOBLASTIN;
ONCOPROTEIN;
SUBUNIT VACCINE;
TEL AML1 FUSION PROTEIN;
TEL-AML1 FUSION PROTEIN;
TRANSCRIPTION FACTOR RUNX1;
WT1 PROTEIN;
ACUTE GRANULOCYTIC LEUKEMIA;
ADOPTIVE TRANSFER;
BIOLOGICAL THERAPY;
CHRONIC MYELOID LEUKEMIA;
CYTOTOXIC T LYMPHOCYTE;
DENDRITIC CELL;
GENE THERAPY;
GENETICS;
HUMAN;
IMMUNOLOGY;
IMMUNOTHERAPY;
METHODOLOGY;
REVIEW;
ADOPTIVE TRANSFER;
CANCER VACCINES;
CORE BINDING FACTOR ALPHA 2 SUBUNIT;
DENDRITIC CELLS;
FUSION PROTEINS, BCR-ABL;
GENE THERAPY;
HUMANS;
IMMUNOTHERAPY;
LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;
LEUKEMIA, MYELOID, ACUTE;
MYELOBLASTIN;
ONCOGENE PROTEINS, FUSION;
RECEPTORS, ANTIGEN, T-CELL;
T-LYMPHOCYTES, CYTOTOXIC;
TISSUE THERAPY;
VACCINES, SUBUNIT;
WT1 PROTEINS;
|
|
EID: 73449124156
PISSN: 00471852
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (3)
|
|
References (20)
|
